siladenoserinol A

an inhibitor of the p53-Hdm2 interaction

Also Known As:

(2R)-3-acetoxy-2-(((2E)-8-((1S,2R,5S,7R)-2-acetoxy-5-(14-((2S)-3-hydroxy-2-(sulfoamino)propoxy)tetradecyl)-6,8-dioxabicyclo(3.2.1)oct-7-yl)-2-octenoyl)oxy)propyl 2-(trimethylammonio)ethyl phosphate

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Márquez-Cadena, Miguel Adrián: 1 article (12/2019)
2.	Qian, Peiyuan: 1 article (12/2019)
3.	Ren, Jingyun: 1 article (12/2019)
4.	Tong, Rongbiao: 1 article (12/2019)
5.	Ye, Wenkang: 1 article (12/2019)

Related Diseases

1.	Neoplasms (Cancer) 12/06/2019 - "Our total synthesis allowed us to further examine their bioactivities, which revealed that (i) siladenoserinols A and H were not cytotoxic against cancer cell lines and (ii) siladenoserinol A and its desulfamate analogue exhibited significant antibacterial activity against Gram-positive bacteria including MRSA. "